Seelos Therapeutics Announces Proposed Public Offering

/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for...

Related Keywords

New York ,United States ,American ,Mike Moyer ,Exchange Commission ,Lifesci Advisors ,American Capital Partners ,World Trade Center ,Seelos Therapeutics Inc ,Nasdaq ,Prnewswire Seelos Therapeutics Inc ,Anthony ,Titan Partners Group ,Partners Group ,Trade Center ,Acute Suicidal Ideation ,Major Depressive Disorder ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Seelo Quarterly Report ,Sci Advisors ,Seelos Therapeutics ,Nc ,